Skip to content
Dementia Patients Assisted by Technological Advances

Dementia Patients Assisted by Technological Advances

The number of patients living with Alzheimer’s disease is projected to rise sharply according to a study conducted by The Lewin Group of Falls Church, VA on the behalf of the Alzheimer’s Association. By the year 2040 more than twice…

The Benefits of The Internet of Medical Things

The Benefits of The Internet of Medical Things

The Centers for Medicare and Medicaid Services forecasts the US Health care system will soon be significantly overwhelmed with seniors requiring medical care. Government medical programs and services, insurers, and manufacturers are tasked with finding ways to reduce the enormity…

Did You Know Hearing Loss Can Lead To Other Health Risks

Did You Know Hearing Loss Can Lead To Other Health Risks

According to a 10-year study by the Journal of the American Medical Association (JAMA) there is a connection between hearing loss and various health risks. The risks include a 50% greater risk of dementia, a 40% greater risk of developing…

How are Medicaid and Medicare Different?

How are Medicaid and Medicare Different?

In the healthcare industry, the acronym LASA, which stands for “look-alike-sound-alike” is used when referring to medications.  When it comes to federal programs, Medicaid and Medicare, in written form, look alike and they do sound alike but work very differently.…

The FDA Approves New Alzheimer’s Drug

The FDA Approves New Alzheimer’s Drug

The US Food and Drug Administration (FDA) recently approved a new drug under the trademark Aduhelm™ to treat Alzheimer’s disease. The drug, Aducanumab, is a therapeutic drug that clinically demonstrates a potential to delay further decline from Alzheimer’s disease and…

Back To Top